Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000498200 | SCV000590274 | uncertain significance | not provided | 2017-06-06 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the HSPB1 gene. The D93N variant has been reported previously as a variant of unknown significance in association with CMT; however, additional clinical information and inheritance pattern were not provided (DiVincenzo et al., 2014). The D93N variant is observed in 3/5180 (0.06%) alleles from individuals of European non-Finnish background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The D93N variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position where amino acids with similar properties to Aspartic acid are tolerated across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Invitae | RCV001084552 | SCV000640208 | likely benign | Charcot-Marie-Tooth disease axonal type 2F | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001172550 | SCV001335611 | uncertain significance | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing |